Results 251 to 260 of about 33,317 (303)

scMOG: A graph neural network method for regulatory relationship‐preserving single‐cell multi‐omics integration

Quantitative Biology, Volume 14, Issue 3, September 2026.
Abstract Single‐cell multi‐omics sequencing technology provides a powerful tool for studying cellular heterogeneity. However, beyond the challenges of sparsity, heterogeneity, and dimensionality differences, a critical challenge in multi‐omics data integration lies in preserving the true regulatory relationships among molecular features.
Yucheng Lu, Xun Zhang, Hongwei Li
wiley   +1 more source

Multi-omics strategies for biomarker discovery and application in personalized oncology. [PDF]

Mol Biomed
Jiang Z, Zhang H, Gao Y, Sun Y.
europepmc   +1 more source

Tumor‐educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation

International Journal of Cancer, Volume 159, Issue 2, Page 302-319, 15 July 2026.
Abstract Tumor‐educated platelets (TEPs) are emerging as a compelling frontier in liquid biopsy, functioning as dynamic, systemic sensors that sequester and process tumor‐derived biomolecules. This interaction imprints an integrated molecular signature of malignancy—spanning the transcriptome, proteome, lipidome, and crucially, the captured genome ...
Whi‐An Kwon, Min‐Kyung Lee, Eunyong Ahn, Heeyeon Kim, Yong Sang Song, Taejin Ahn   +5 more
wiley   +1 more source

Correction. [PDF]

Epigenomics
europepmc   +1 more source

Twenty-five years of briefings in bioinformatics. [PDF]

Brief Bioinform
Bishop M.
europepmc   +1 more source

Integrative multi-omics profiling for early diagnosis, stratification and personalized management of chronic kidney disease: a new paradigm. [PDF]

Clin Exp Med
Li Y, Taherkhani S, Saidov K, Matniyozova M.   +3 more
europepmc   +1 more source

Dissecting Pirtobrutinib Resistance in Mantle Cell Lymphoma Through Single‐Cell Multi‐Omics

American Journal of Hematology, Volume 101, Issue 7, Page 1632-1649, July 2026.
ABSTRACT Pirtobrutinib (PBN), a non‐covalent BTK inhibitor, has been approved by the FDA for relapsed/refractory mantle cell lymphoma (MCL); however, resistance to PBN has been observed. To dissect the molecular dynamics driving PBN resistance, we performed integrative single‐cell multi‐omic profiling (scRNA‐seq, scATAC‐seq, and scDNA‐seq) on ...
Fangfang Yan, Yang Liu, Heng‐Huan Lee, Wei Wang, Joseph McIntosh, Yijing Li, Jovanny Vargas, Yue Fei, Sairah Ahmed, Lukas M. Simon, Michael Wang   +10 more
wiley   +1 more source

Multi-omics-driven biomarker discovery in autoimmune diseases: a comprehensive review. [PDF]

Front Immunol
Zhang Y, Xu H, Xu L, Jiang S, Yu Y, Zhao H.   +5 more
europepmc   +1 more source

Science of omics: a molecular space odyssey

Experimental Physiology, EarlyView.
Salomé Coppens, Christophe Hirtz, Margaux Vignon, Damian M. Bailey   +3 more
wiley   +1 more source

Correction: Commentary: RNA transcripts in salivary extracellular vesicle cargo isolated from aged populations. [PDF]

Front Aging
Yin L.
europepmc   +1 more source